ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,736Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 978

$573K Total Retail Price of All Prescriptions

Rank: 28 out of 978

703 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 703 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 703 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 7,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 731 555 1 2
HYDROCODONE-ACETAMINOPHEN 531 313 S3 2 17
LEVOTHYROXINE SODIUM 507 395 3 4
OMEPRAZOLE 481 298 4 3
LISINOPRIL 437 302 5 1
METFORMIN HCL 299 219 6 7
FUROSEMIDE 255 196 7 9
PRAVASTATIN SODIUM 217 132 8 16
AMLODIPINE BESYLATE 215 156 9 6
METOPROLOL SUCCINATE 209 165 10 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 207 127 11 36
OXYCODONE HCL 205 71 S2 12 23
METOPROLOL TARTRATE 204 155 13 10
ATORVASTATIN CALCIUM 195 170 14 12
FLUOXETINE HCL 175 138 15 42
HYDROCHLOROTHIAZIDE 167 116 16 5
ZOLPIDEM TARTRATE 165 103 17 32
IBUPROFEN 128 57 18 38
CARVEDILOL 121 112 19 55
SERTRALINE HCL 121 82 19 21
WARFARIN SODIUM 117 89 21 11
CARISOPRODOL 117 27 R 21 137
ATENOLOL 116 96 23 8
PROAIR HFA 113 63 24 19
LOSARTAN POTASSIUM 109 100 25 22
GLYBURIDE 109 109 R 25 44
GABAPENTIN 106 54 27 15
CITALOPRAM HBR 101 76 28 14
TAMSULOSIN HCL 92 77 29 33
FLUTICASONE PROPIONATE 88 57 30 28
DIOVAN HCT 84 67 31 154
TRAZODONE HCL 83 52 32 18
PAROXETINE HCL 81 37 33 52
OXYCODONE-ACETAMINOPHEN 79 22 S2 34 25
CYCLOBENZAPRINE HCL 78 17 R 35 62
LANTUS 78 58 35 40
NEXIUM 71 25 37 77
DOXYCYCLINE HYCLATE 69 47 38 146
DIOVAN 69 69 38 43
ADVAIR DISKUS 69 38 38 35
ALPRAZOLAM 69 55 38 172
FENOFIBRATE 68 36 42 53
ALENDRONATE SODIUM 61 53 43 20
COMBIVENT 59 49 44 110
KLOR-CON M20 58 55 45 66
MIRTAZAPINE 58 47 45 31
CLOPIDOGREL 54 38 47 61
FAMOTIDINE 52 35 48 107
CRESTOR 51 26 49 30
PREDNISONE 51 38 49 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.